Jayson Yuan
Palo Alto Investors LP
Value
718.4M
Stocks
49 Stocks (8 new)
Turnover
8.67%
CIK
1306923
Top Holdings
INSM(11.86%) FOLD(10.32%) PTCT(9.56%) ACAD(9.24%) BMRN(6.17%)
About Investor
Established investor leading Palo Alto Investors LP, with expertise in fundamental analysis and long-term value creation. Has built a strong track record by focusing on fundamental research and maintaining a consistent investment approach through various market environments.
Investor Philosophy
Specializes in fundamental analysis and long-term value creation through a disciplined investment approach. Emphasizes thorough research, risk management, and identifying opportunities across market cycles. Known for maintaining a consistent strategy while adapting to changing market conditions.
Jayson Yuan Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Palo Alto Investors LP | Feb 13, 2025 | SC 13G/A |
| RVNC | Revance Therapeutics, Inc. | Palo Alto Investors LP | Feb 14, 2024 | SC 13G/A |
| EHTH | eHealth, Inc. | Palo Alto Investors LP | Feb 14, 2024 | SC 13G/A |
| KPTI | Karyopharm Therapeutics Inc. | Palo Alto Investors LP | Feb 14, 2024 | SC 13G/A |
| ALIM | Alimera Sciences, Inc. | Palo Alto Investors LP | Apr 03, 2023 | SC 13G/A |
| VNDA | Vanda Pharmaceuticals, Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| RVNC | Revance Therapeutics, Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| KPTI | Karyopharm Therapeutics Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| INSM | Insmed Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| EPZM | Epizyme, Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| EHTH | eHealth, Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
| ALIM | Alimera Sciences, Inc. | Palo Alto Investors LP | Feb 14, 2023 | SC 13G/A |
